CARLSBAD, Calif.--(BUSINESS WIRE)--Shrink Nanotechnologies, Inc. (“Shrink”) (OTCBB:INKN), an innovative nanotechnology company developing products and licensing opportunities in the solar energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that its scientific founder, Dr. Michelle Khine, has received a multi-year and multi-million dollar grant from the National Institutes of Health (NIH) to work on her shrink-film based diagnostic platforms. In addition to the grant, she was given the NIH Director’s New Innovator Award. The core of the technology underlying this grant is being commercialized by Shrink Nanotechnologies in the form of its NanoShrink branded shrink films, StemDisc cell culturing devices as well as numerous additional products that are under development using this innovative shrink-film based platform. Shrink’s initial suites of products are slated for commercial sale later this year.
